APA (7th ed.) Citation

Hattingen, E., Bähr, O., Rieger, J., Blasel, S., Steinbach, J., & Pilatus, U. (2013). Phospholipid metabolites in recurrent glioblastoma: In vivo markers detect different tumor phenotypes before and under antiangiogenic therapy. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Hattingen, Elke, Oliver Bähr, Johannes Rieger, Stella Blasel, Joachim Steinbach, and Ulrich Pilatus. Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes Before and Under Antiangiogenic Therapy. Public Library of Science (PLoS), 2013.

MLA (8th ed.) Citation

Hattingen, Elke, et al. Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes Before and Under Antiangiogenic Therapy. Public Library of Science (PLoS), 2013.